Areas of Specialization

Erectile Dysfunction

Comprehensive vascular and neurological evaluation with individualized therapeutic protocols.

Erectile dysfunction is rarely a single-cause condition. Our evaluation examines vascular supply, neurological signalling, endocrine status, medication effects, and psychological contributors before any treatment is proposed.

• —Cardiovascular and metabolic screening
• —Doppler assessment where clinically indicated
• —Full hormonal panel review
• —Medication and lifestyle reconciliation

Hormonal Imbalance

Detailed endocrine assessment and medically supervised optimization.

Testosterone, thyroid, and adrenal function influence energy, mood, body composition, and sexual health. We interpret results in clinical context rather than against a single reference range.

• —Morning total and free testosterone
• —LH, FSH, SHBG, prolactin and oestradiol
• —Thyroid and metabolic markers
• —Structured re-testing and dose review

Premature Ejaculation

Multi-modal evaluation addressing physiological and neurobehavioral factors.

Treatment begins with distinguishing lifelong from acquired presentations, then addressing the physiological and behavioural drivers together rather than in isolation.

• —Structured clinical history and timing assessment
• —Screening for prostatic and thyroid contributors
• —Pharmacological options where appropriate
• —Behavioural technique coaching

Low Libido

Clinical review of hormonal, metabolic, and lifestyle determinants.

Reduced desire is assessed as a whole-body signal — sleep, stress load, metabolic health, relationship context, and endocrine function are all reviewed.

• —Endocrine and metabolic profiling
• —Sleep and recovery assessment
• —Medication side-effect review
• —Longitudinal follow-up

Performance Anxiety

Integrated medical assessment with behavioral health strategies.

Anticipatory anxiety frequently coexists with a physiological trigger. We treat both concurrently so improvement is durable rather than situational.

• —Confidential psychological screening
• —Physiological co-factor exclusion
• —Short-course pharmacological support
• —Coordinated behavioural sessions

Peyronie's Disease

Specialized evaluation with therapeutic options tailored to clinical staging.

Management depends on whether the condition is in the active inflammatory phase or the stable phase. Staging is established before any intervention is recommended.

• —Curvature and plaque documentation
• —Ultrasound assessment where indicated
• —Phase-appropriate therapeutic planning
• —Surgical referral pathway when required